Enzo Total Assets from 2010 to 2024

ENZ Stock

USD 0.98 0.01 1.03%

Enzo Biochem Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

1986-07-31

Previous Quarter

93.5 M

Current Value

85.8 M

Quarterly Volatility

27.5 M

Black Monday

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Enzo Biochem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enzo Biochem's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.5 M, Interest Expense of 187.2 K or Total Revenue of 63.1 M, as well as many indicators such as Price To Sales Ratio of 1.73, Dividend Yield of 2.0E-4 or PTB Ratio of 0.98. Enzo financial statements analysis is a perfect complement when working with Enzo Biochem Valuation or Volatility modules.

Check out the analysis of Enzo Biochem Correlation against competitors.

For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

Latest Enzo Biochem's Total Assets Growth Pattern

Below is the plot of the Total Assets of Enzo Biochem over the last few years. Total assets refers to the total amount of Enzo Biochem assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Enzo Biochem books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Enzo Biochem's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Enzo Biochem's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 85.76 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Enzo Total Assets Regression Statistics

	Arithmetic Mean	92,952,066
	Geometric Mean	90,601,077
	Coefficient Of Variation	22.38
	Mean Deviation	18,101,653
	Median	100,578,996
	Standard Deviation	20,800,441
	Sample Variance	432.7T
	Range	62.9M
	R-Value	0.66
	Mean Square Error	265.8T
	R-Squared	0.43
	Significance	0.01
	Slope	3,048,189
	Total Sum of Squares	6057.2T

Enzo Total Assets History

	2024	100.6 M
	2023	85.8 M
	2022	121.9 M
	2021	95.9 M
	2020	113.7 M
	2019	112.5 M
	2018	106.6 M

Other Fundumenentals of Enzo Biochem

Intangibles To Total Assets

Enzo Biochem Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Accounts Payable	Short Term Debt	Common Stock	Good Will	Property Plant Equipment	Short Term Investments	Current Deferred Revenue	Long Term Debt	Net Tangible Assets	Capital Surpluse	Short Long Term Debt	Long Term Debt Total	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.83	-0.54	-0.15	-0.18	0.23	0.9	-0.59	0.01	0.1	0.47	0.0	0.47	0.14	-0.44	0.37	0.79	0.41	-0.35	0.42	-0.3	-0.28	-0.44	0.24
Total Stockholder Equity	0.83		-0.77	-0.33	0.17	-0.34	0.87	-0.38	0.25	-0.2	0.58	-0.09	0.24	-0.14	-0.4	0.09	0.84	0.37	-0.58	0.16	-0.1	-0.08	-0.12	0.18
Net Debt	-0.54	-0.77		0.14	-0.05	0.44	-0.8	0.1	-0.02	0.49	-0.37	0.12	0.2	0.49	0.24	0.41	-0.78	-0.39	0.4	0.35	-0.5	-0.07	-0.19	-0.25
Retained Earnings	-0.15	-0.33	0.14		-0.38	0.33	-0.01	-0.33	-0.34	-0.27	-0.9	0.49	-0.41	0.38	-0.39	-0.22	-0.2	-0.42	0.16	-0.16	0.19	0.35	0.35	-0.28
Net Receivables	-0.18	0.17	-0.05	-0.38		-0.54	-0.12	0.07	0.92	0.15	0.28	-0.31	-0.21	-0.21	0.15	-0.12	-0.16	-0.42	0.12	-0.08	0.17	0.6	0.55	-0.61
Total Liab	0.23	-0.34	0.44	0.33	-0.54		0.01	-0.35	-0.36	0.53	-0.2	0.05	0.39	0.49	-0.03	0.49	-0.12	0.01	0.43	0.45	-0.31	-0.28	-0.48	-0.01
Total Current Assets	0.9	0.87	-0.8	-0.01	-0.12	0.01		-0.54	-0.01	-0.21	0.39	-0.07	0.21	-0.01	-0.48	0.01	0.9	0.42	-0.45	0.08	0.06	-0.09	-0.12	0.2
Intangible Assets	-0.59	-0.38	0.1	-0.33	0.07	-0.35	-0.54		-0.09	-0.18	0.01	-0.11	-0.24	-0.47	0.84	-0.44	-0.42	-0.09	0.14	-0.51	0.33	0.0	0.17	0.16
Accounts Payable	0.01	0.25	-0.02	-0.34	0.92	-0.36	-0.01	-0.09		0.33	0.29	-0.32	-0.09	-0.11	0.02	0.08	-0.1	-0.49	0.18	0.12	0.03	0.58	0.43	-0.71
Short Term Debt	0.1	-0.2	0.49	-0.27	0.15	0.53	-0.21	-0.18	0.33		0.18	-0.14	0.4	0.27	0.08	0.55	-0.28	-0.12	0.65	0.5	-0.34	-0.11	-0.35	-0.15
Common Stock	0.47	0.58	-0.37	-0.9	0.28	-0.2	0.39	0.01	0.29	0.18		-0.62	0.54	-0.29	0.16	0.3	0.55	0.59	-0.34	0.27	-0.18	-0.39	-0.41	0.27
Good Will	0.0	-0.09	0.12	0.49	-0.31	0.05	-0.07	-0.11	-0.32	-0.14	-0.62		-0.36	0.18	-0.24	-0.12	-0.31	-0.32	0.06	-0.11	-0.21	0.07	0.02	0.16
Property Plant Equipment	0.47	0.24	0.2	-0.41	-0.21	0.39	0.21	-0.24	-0.09	0.4	0.54	-0.36		0.56	-0.03	0.63	0.36	0.49	-0.31	0.6	-0.61	-0.52	-0.63	0.33
Short Term Investments	0.14	-0.14	0.49	0.38	-0.21	0.49	-0.01	-0.47	-0.11	0.27	-0.29	0.18	0.56		-0.31	0.33	-0.06	-0.1	-0.12	0.34	-0.53	-0.03	-0.14	-0.06
Current Deferred Revenue	-0.44	-0.4	0.24	-0.39	0.15	-0.03	-0.48	0.84	0.02	0.08	0.16	-0.24	-0.03	-0.31		-0.18	-0.45	-0.13	0.3	-0.25	0.19	0.02	0.07	-0.01
Long Term Debt	0.37	0.09	0.41	-0.22	-0.12	0.49	0.01	-0.44	0.08	0.55	0.3	-0.12	0.63	0.33	-0.18		0.04	0.07	0.04	0.99	-0.71	-0.3	-0.6	-0.09
Net Tangible Assets	0.79	0.84	-0.78	-0.2	-0.16	-0.12	0.9	-0.42	-0.1	-0.28	0.55	-0.31	0.36	-0.06	-0.45	0.04		0.69	-0.62	0.1	0.02	-0.32	-0.26	0.39
Capital Surpluse	0.41	0.37	-0.39	-0.42	-0.42	0.01	0.42	-0.09	-0.49	-0.12	0.59	-0.32	0.49	-0.1	-0.13	0.07	0.69		-0.49	0.04	-0.12	-0.79	-0.63	0.82
Short Long Term Debt	-0.35	-0.58	0.4	0.16	0.12	0.43	-0.45	0.14	0.18	0.65	-0.34	0.06	-0.31	-0.12	0.3	0.04	-0.62	-0.49		0.0	0.29	0.31	0.16	-0.38
Long Term Debt Total	0.42	0.16	0.35	-0.16	-0.08	0.45	0.08	-0.51	0.12	0.5	0.27	-0.11	0.6	0.34	-0.25	0.99	0.1	0.04	0.0		-0.7	-0.25	-0.55	-0.13
Cash And Equivalents	-0.3	-0.1	-0.5	0.19	0.17	-0.31	0.06	0.33	0.03	-0.34	-0.18	-0.21	-0.61	-0.53	0.19	-0.71	0.02	-0.12	0.29	-0.7		0.52	0.69	-0.15
Net Invested Capital	-0.28	-0.08	-0.07	0.35	0.6	-0.28	-0.09	0.0	0.58	-0.11	-0.39	0.07	-0.52	-0.03	0.02	-0.3	-0.32	-0.79	0.31	-0.25	0.52		0.92	-0.78
Net Working Capital	-0.44	-0.12	-0.19	0.35	0.55	-0.48	-0.12	0.17	0.43	-0.35	-0.41	0.02	-0.63	-0.14	0.07	-0.6	-0.26	-0.63	0.16	-0.55	0.69	0.92		-0.6
Capital Stock	0.24	0.18	-0.25	-0.28	-0.61	-0.01	0.2	0.16	-0.71	-0.15	0.27	0.16	0.33	-0.06	-0.01	-0.09	0.39	0.82	-0.38	-0.13	-0.15	-0.78	-0.6

Click cells to compare fundamentals

About Enzo Biochem Financial Statements

Enzo Biochem investors use historical fundamental indicators, such as Enzo Biochem's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Enzo Biochem. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	85.8 M	100.6 M
Intangibles To Total Assets	0.07	0.13

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Enzo Stock Analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC